Skip to main content

Alacris Attains Illumina CSPro Certification for NGS

NEW YORK (GenomeWeb News) – Alacris Theranostics today said that is has gained Illumina CSPro certification for next-generation sequencing.

Illumina CSPro is a collaborative service provider partnership aimed at providing high quality data for genetic analysis applications, and applicants undergo a two-phase process that includes minimum data generation, data certification, and an onsite audit of the facility and processes.

Based in Berlin, Alacris specializes in personalized medicine for cancer patient diagnosis, treatment, and stratification, it said on its website. It uses a systems biology approach, called ModCell, developed at the Max Planck Institute for Molecular Genetics and licensed to Alacris. The approach is based on next-generation sequencing to provide information about the genome and transcriptome, and incorporates kinetic pathway information, and mutation and drug databases.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.